Summary. The outputs of prostaglandin (PG) F-2\g=a\, PGE-2 and 6-keto-PGF-1\g=a\from 
Introduction
In several non-primate mammalian species, prostaglandin (PG) F-2a released from the uterus is responsible for regression of the corpora lutea in the ovary (see Horton & Poyser, 1976; Poyser, 1981) . In the guinea-pig, oestradiol acting on a progesterone-primed uterus stimulates endometrial PGF-2a production (Blatchley & Poyser, 1974; Poyser, 1983a, b) . Oxytocin has no effect on uterine PG output in the non-pregnant guinea-pig (Poyser & Brydon, 1983; Riley & Poyser, 1987a) . Increased oestradiol output from the ovary on Day 10 (Joshi et al, 1973) precedes increased PGF2a output from the uterus on Day 11 (Blatchley et al, 1972; Earthy et al, 1975; Antonini et al, 1976) in the guinea-pig, indicating a cause and effect relationship. Since many actions of oestradiol on the uterus are mediated through increased protein synthesis (see Brenner & West, 1975) , the effects of protein synthesis inhibitors on the production of PGs by guinea-pig endometrium have been investigated. Three inhibitors of protein synthesis with different mechanisms of action were 'Reprint requests to N. L. Poyser. Progesterone was measured as described previously (Poyser & Horton, 1975) , using an antibody raised in this laboratory and whose cross-reactivities have been reported previously (Poyser, 1983a (Poyser, , 1984 . The intra-assay and inter-assay coefficients of variation were 10-8% and 10-1%, respectively. The (1981) . Endometrial tissue was weighed and washed 3 times with 1 ml Medium 199 at 4°C. The tissue was placed in 1 ml lysis buffer (8 M-urea, 1% v/v sodium dodecyl sulphate and 5% v/v mercaptoethanol), shaken, and incubated at 4DC overnight. Tissue proteins were then extracted by rapidly freezing and thawing (with mixing) the solution 3 times, followed by centrifugation at 1400 g for 15 min. To four 200 pi volumes of the supernatant were added 300 µ saline (9g/l) containing bovine serum albumin (01%) and L-leucine (01%). Proteins were precipitated by adding 500 µ 10% w/v trichloroacetic acid (TCA) and allowing to stand for 30 min at 4°C. Each solution was centrifuged at 1400 g for 15 min and the superna¬ tant was discarded. The precipitate was washed with 500 pi 5% TCA and centrifuged at 1400g for 15 min. The supernatant was removed and the precipitate was dissolved by incubating with 100 µ formic acid for 30 min at room temperature. The amount of radioactivity in each sample was measured in a liquid scintillation counter.
Secreted proteins. The technique used was based on the method of Strinden & Shapiro (1983) . Each sample of culture medium was centrifuged at 1000 g for 10 min. To four 200 pi volumes of the supernatant were added 10 µ of a solution containing bovine serum albumin (20 mg/ml) in saline (9g/l), and 300 pi 10% TCA. After incubation for 30 min at 4°C, each sample was centrifuged at 1400 g for 15 min. The supernatant was discarded, and the precipitate was washed with 300 pi 5% TCA and centrifuged at 1400 g for 15 min, a procedure which was repeated 3 times. Finally, the supernatant was discarded, and the precipitate was dissolved by incubating with 100 µ formic acid for 30 min at room temperature. The amount of radioactivity present was measured in a liquid scintillation counter. (controls) , and 7 pairs of dishes were each treated with one of the following protein synthesis inhibitors at one of the concentrations: actinomycin D (1, 10 and 50 µg/ml), cyclohexi¬ mide (10 and 50 µg/ml), puromycin (10 and 50 µg/ml). These 18 dishes were equally divided between 2 Kilner jars such that each jar contained 2 control dishes and one dish from each pair of dishes. The endometrium was cultured for 24 h and the culture medium (containing the appropriate treatment) was changed every 6h. The samples of culture medium were stored at -20°C before being assayed, without extraction, for PGF-2a, PGE-2 and 6-keto-PGF-la.
Sources of material
Results. The basal outputs of PGF-2a, PGE-2 and 6-keto-PGF-la from Day-7 and Day-15 guinea-pig endometrium cultured for 24 h and sampled at 6-h intervals are shown in Fig. 1 . The outputs of PGF-2a, PGE-2 and 6-keto-PGF-la from Day-15 endometrium and of 6-keto-PGF-la from Day-7 endometrium significantly (P < 005) decreased with time. The output of PGF-2a from Day-7 endometrium significantly (P < 005) increased up to 18 h and then tended to fall. The outputs of PGE-2 from Day-7 endometrium showed a similar trend, but the changes were not significant. PGF-2a was the major PG released from Day-15 endometrium, with much lower quantities of 6-keto-PGF-la and PGE-2. Initially, 6-keto-PGF-la was the major PG released from Day-7 endometrium, with lower amounts of PGF-2a and PGE-2. However, as 6-keto-PGF-la output declined and PGF-2a output increased, PGF-2a was the major PG released from Day-7 endometrium after 18 and 24h. The outputs of PGF-2a and PGE-2 were significantly (P < 005) greater from Day-15 endometrium than from Day-7 endometrium at all times, whereas 6-keto-PGF-la output was significantly (P < 005) greater from Day-15 endometrium only after 12h of culture.
Actinomycin D, cycloheximide and puromycin had no effect on the outputs of PGF-2a, PGE-2 and 6-keto-PGF-la from Day-7 endometrium during the first 6 h of culture, except that cycloheximide (50µg/ml) significantly (P < 005) stimulated PGE-2 output. Actinomycin D (10 and 50 µg/ml, but not 1 µg/ml), cycloheximide (10 and 50 µg/ml) and puromycin (10 and 50 µg/ml) significantly (P < 005) inhibited PGF-2a output from Day-7 endometrium after 12, 18 and 24 h of culture (Fig. 2) . Actinomycin D (10 and 50 µg/ml, but not 1 µg/ml), cycloheximide (10 µg/ml) and puromycin (10 and 50 µg/ml) significantly (P < 005) inhibited PGE-2 output from Day-7 endome¬ trium after 18 and 24 h. PGE-2 output after 12 h was inhibited only by puromycin (10 µg/ml) and actinomycin D (50 µg/ml). Actinomycin D (all 3 concentrations) and puromycin (50 µg/ml) had no effect on 6-keto-PGF-la output from Day-7 endometrium. Cycloheximide (10 and 50 µg/ml) and puromycin (10µg/ml) significantly (P < 005) inhibited 6-keto-PGF-la output from Day-7 endometrium after 12, 18 and 24 h of culture (Fig. 2) .
Actinomycin D (50 µg/ml, but not 1 and 10 µg/ml except for 10 µg/ml after 24 h), cycloheximide (10 and 50µg/ml) and puromycin (10 and 50 µg/ml, but not 10µg/ml after 6h) significantly (P < 005) reduced PGF-2a output from Day-15 endometrium after 6, 12, 18 and 24 h of culture (Fig. 3) . None of the protein synthesis inhibitors affected the outputs of PGE-2 and 6-keto-PGF-la Immediately after the jars were placed in the incubator, two amounts (12-20 mg) of the remain¬ ing endometrium from each animal were weighed accurately and were each homogenized in 5 ml Krebs' solution (for composition, see Mitchell et al, 1977) containing 2µg sodium arachidonate. Each homogenate was gassed with 95% 02 and 5% C02, and was incubated at 37°C for 60 min.
PGs were extracted from the incubates as described previously (Poyser, 1983a) and were stored in 5 ml ethyl acetate at -20°C.
After 6 h of incubation, one control dish and one dish containing each treatment was removed from each jar and the endometrium was processed as described above. The remaining 8 dishes were also removed; the culture medium was withdrawn and stored at -20°C, and was replaced with fresh medium containing the same concentrations of the same protein synthesis inhibitors. These dishes were placed back into the jars, the endometrium was cultured for a further 6 h, and then the culture medium was withdrwn and stored at -20°C. The endometrium in each dish was pro¬ cessed as described above. The amounts of PGF-2a, PGE-2 and 6-keto-PGF-la in the samples of culture medium and in ethyl acetate extracts of the endometrial incubates were measured by radioimmunoassay.
Results. The amounts of PGF-2a, PGE-2 and 6-keto-PGF-la synthesized by homogenates of Day-7 and Day-15 endometrium were significantly (P < 005) greater after 6 and 12 h of culture than before culture started, except for PGF-2a and PGE-2 production by Day-7 tissue at 6h. Actinomycin D (50µg/ml), cycloheximide (10µg/ml) and puromycin (50µg/ml) significantly (P < 005) reduced the amounts of PGF-2a, PGE-2 and 6-keto-PGF-la synthesized by homoge¬ nates of Day-7 and Day-15 endometrium after 6 and 12 h of culture (except for actinomycin D on 6-keto-PGF-la production by Day-15 tissue after 6h; Table 1 ). Furthermore, the amounts of PGF-2a and PGE-2 synthesized by homogenates of Day-7 and Day-15 guinea-pig endometrium following 12 h of culture in the presence of cycloheximide and puromycin were significantly (P < 005) lower than before culture (Oh; Table 1 ). The outputs of PGF-2a, PGE-2 and 6-keto-PGF-la at 6 and 12 h from Day-7 and Day-15 endometrium in culture and the effects of the protein synthesis inhibitors on PG output were essentially similar to the findings in Exp. 1 (compare Table  1 Methods. Each uterus from five Day-7 and five Day-15 guinea-pigs was separated into its 2 horns; each uterine horn was weighed, opened by 'cutting' longitudinally, and superfused with Krebs' solution (5 ml/min) at 37°C as described previously (Poyser & Brydon, 1983) . Each horn was superfused initially for a 'settling period' of 60 min, and then samples of superfusate were collected for 10-min periods over the next 80 min (i.e. 8 samples/uterine horn). During the collec¬ tion of samples 4 and 5, actinomycin D (50 µg/ml) was added to the Krebs' solution superfusing one uterine horn from each animal. After collection, PGs were extracted from the samples of superfusate, as outlined previously (Poyser, 1987) , and were stored in 10 ml ethyl acetate at -20°C. Immediately after the period of superfusion, the endometrium and myometrium forming each uterus were separated, weighed, homogenized in 10 ml Krebs' solution, incubated, and PGs were extracted and stored as in Exp. 2. The amounts of PGF-2a, PGE-2 and 6-keto-PGF-la present in all ethyl acetate extracts were measured by radioimmunoassay. This experiment was repeated twice more, substituting cycloheximide (50 µg/ml) or puromycin (50 µg/ml) for actino¬ mycin D.
Results. The outputs of PGF-2a, PGE-2 and 6-keto-PGF-la from the Day-7 and Day-15 uterus superfused in vitro were not reduced by actinomycin D, cycloheximide and puromycin (all at 50 µg/ ml). In fact, stimulation of PG output was often observed (Tables 2 and 3 ). Actinomycin D signifi¬ cantly (P < 005) increased PGF-2a output from the Day-7 uterus, PGE-2 output from the Day-15 Table 1 . Effects of actinomycin D (Actin. D; 50µg/ml), cycloheximide (Cyclohex.; 10µg/ml) and puro¬ mycin (Puromy.; 50 µg/ml) on the mean ( +s.e.m., n = 10) amounts of prostaglandin (PG) F-2a, PGE-2 and 6-keto-PGF-la (6-KF) synthesized by homogenates of (synthesizing ability) and released from (Table 4) . (Fig. 4) . Actinomycin D (50µg/ml), cycloheximide (10µg/ml) and puromycin (50µg/ml) significantly (P < The outputs of PGF-2a and PGE-2 from Day-15 guinea-pig endometriu myometrium cultured for 24h were significantly ( < 001) reduced following t of intrauterine actinomycin D on Day 10. The output of 6-keto-PGF-la from ( Significantly ( < 001) higher than myometrial control value for 6-KF.
was unaffected, while 6-keto-PGF-la output from the myometrium was significantly (P < 001) increased (Table 5) . Mean ( +s.e.m., = 5) plasma progesterone concentrations were significantly (P < 001) higher in the actinomycin D-treated guinea-pigs (3-99 + 0-49 ng/ml) than in the control guinea-pigs (0-59 ± 010 ng/ml), showing that luteal regression had been prevented.
Discussion
The outputs of PGF-2a and PGE-2 from guinea-pig endometrium in culture for 24 h were higher on Day-15 than on Day-7 of the cycle. This is not due to differences in metabolism since PG metabolism by the guinea-pig uterus is low (Poyser, 1979 (Poyser & Brydon, 1983) .
The outputs of PGF-2a, PGE-2 and 6-keto-PGF-la from Day-15 endometrium and of 6-keto-PGF-la from Day-7 endometrium declined during the 24-h period of culture. The output of PGF-2a from Day-7 endometrium increased during 18 h of culture. This stimulation may be due to the removal of the inhibitory influence of progesterone on endometrial PGF-2a synthesis in the guinea-pig (Leaver & Seawright, 1982; Riley & Poyser, 1987a) Actinomycin D (10 and 50µg/ml, but not 1 µg/ml), cycloheximide and puromycin (both at 10 and 50 µg/ml) inhibited PGF-2a output from Day-7 and Day-15 guinea-pig endometrium, although only PGF-2a output from Day-15 endometrium was inhibited during the first 6-h period of culture. Actinomycin D was less potent than the other two protein synthesis inhibitors. All three compounds generally inhibited the outputs of PGE-2 and 6-keto-PGF-la, but their effects were more variable than on PGF-2a output. Only actinomycin D (50 µg/ml) inhibited the outputs of PGE-2 and 6-keto-PGF-la from Day-15 endometrium during the first 6 h period of culture.
PG output from rat skeletal muscle is very rapidly inhibited (within 10 min) by protein synthesis inhibitors (Turinsky, 1985; Turinsky & Loegering, 1985; Fagan & Goldberg, 1986 Previous studies have shown that the intrauterine administration of actinomycin D on Day 10 reduces the outputs of PGF-2a and PGE-2, but not of 6-keto-PGF-la, from the Day-15 uterus superfused in vitro, and extends oestrous cycle length due to the maintenance of the corpora lutea beyond their normal life-span as a consequence of reduced uterine PGF-2a production (Poyser, 1979; Poyser & Riley, 1987) . In the present study, the intrauterine administration of actinomycin D on Day 10 reduced the outputs of PGF-2a and PGE-2 on Day 15 from the endometrium, but not from the myometrium, when the tissues were cultured for 24 h, which shows that the long-term inhibitory effect of actinomycin D on PG output from the uterus is specific to the endometrium. Furthermore, actinomycin D treatment on Day 10 had no effect on 6-keto-PGF-la output on Day 15 from the endometrium, and stimulated output from the myometrium. The amounts of cellular and secreted proteins synthesized by (Poyser & Brydon, 1983; Poyser, 1983a) . Oestradiol causes the maximum increase in endometrial PGH concentration, an effect which is reduced by progesterone (Poyser, 1983a) . However, oestradiol causes only a small release of PGF-2a from the guinea-pig uterus, and progesterone priming is needed for oestradiol to produce a large release of PGF-2a (Poyser, 1983b) . Also, in the present study, PG output from Day-15 endometrium was generally lower whereas endometrial PGH synthase concentrations were generally higher after 6 h of culture than after 12 h. The increase in PGF-2a output from Day-7 endometrium during culture may be connected with the increase in endometrial PGH synthase concentration, although an increase in enzyme concentration cannot be the sole cause since endometrial 6-keto-PGF-la output fell during the culture period. Therefore, the supply of substrate (i.e. arachidonic acid), and not changes in PGH synthase concentration, is the rate-limiting step in endometrial PG synthesis. However, the supply of arachidonic acid is not dependent upon changes in the endometrial concentration of phospholipase (PL) A-2, since the amounts of PLA-2 in the guinea-pig endometrium are more than sufficient to account for the amounts of PGF-2a synthesized on Days 7 and 15 of the cycle (Downing & Poyser, 1983) .
Previous studies have indicated that oestradiol, acting on a progesterone-primed uterus, acti¬ vates PLA-2 to release arachidonic acid, from phosphatidylcholine and phosphatidylethanolamine, which from Day 11 of the cycle is preferentially directed into the PGF-2a-forming pathway (Leaver & Poyser, 1981; Downing & Poyser, 1983; Ning et al., 1983; Poyser, 1983b Poyser, , 1987 Ning & Poyser, 1984) . This stimulation of endometrial PGF-2a synthesis requires intracellular and extracellular Ca2+ (Riley & Poyser, 1987b ), but is not dependent upon activation of the phosphatidylinositol (PI) cycle (Ning & Poyser, 1984) . The present study indicates that endometrial PGF-2a synthesis in the guinea-pig is also dependent upon protein synthesis, and this is consistent with a previous suggestion (Poyser, 1984) that "oestradiol stimulates the synthesis in the endometrium of a calcium-mobilizing protein which, on a uterus primed with progesterone, causes the influx of extra¬ cellular Ca2+ and/or release of intracellular Ca2 + ". The increase in intracellular Ca2+ concen¬ tration then activates PLA-2, possibly via an interaction with calmodulin (Poyser, 1985a, b; Riley & Poyser, 1987b) . Since protein synthesis inhibitors inhibit endometrial PG output on Days 7 and 15, it would appear that the synthesis of such a protein occurs throughout the cycle and that its synthesis is stimulated following the increased release of oestradiol from the ovary after Day 10 (Joshi et al, 1973) . However, only from Day 11 is the arachidonic acid released directed into the PGF-2a-forming pathway.
The intrauterine administration of actinomycin D in sheep inhibits regression of the corpus luteum (French & Casida, 1973) , indicating that endometrial PGF-2a production in the sheep is also dependent upon protein synthesis. Actinomycin D and cycloheximide administered systemically to ovariectomized rats did not prevent the stimulation of uterine PG synthesis by oestradiol (Castracane & Jordan, 1976) . However, actinomycin D administered systemically to guinea-pigs failed to affect uterine PG synthesis (Poyser, 1979) , so the study on rats needs repeating but with the protein synthesis inhibitors being administered by the intrauterine route. Actinomycin D also failed to prevent the stimulation by oestradiol of PG synthesis by human endometrial, epithelial cells in culture (Smith & Kelly, 1987) . However, it was not established that the concentrations of actinomycin D used (1-100 ng/ml) inhibited protein synthesis, and they are much lower than the concentrations ( > 1 µg/ml) required in the present study to inhibit endometrial prostaglandin and protein syntheses. A more detailed study on the effects of protein synthesis inhibitors on PG synthesis and protein synthesis in the human endometrium is required. Prostaglandin synthesis by fibroblasts, skeletal muscle, macrophages, brain, and vascular endothelial cells is dependent upon protein synthesis (Pong et al, 1977; Bonney et al, 1980; Townsend et al, 1984; Turinsky, 1985; Clark et al, 1986) . A protein of MT 28 000, which activates PLA-2 and is involved in the stimulation of PG synthesis, has been isolated from vascular endothelial cells (Clark et al, 1987 (Clark et al, , 1988 . Whether this protein is present in the endometrium and is responsible for the stimulation of endometrial PGF-2a synthesis requires further study.
